Antigen/Mitogen-Stimulated Lymphocyte Proliferation

Measuring Immunity: Basic Biology and Clinical Assessment

Volumn , Issue , 2005, Pages 361-368

  Whiteside, Theresa L ^a  

^a UNIVERSITY OF PITTSBURGH CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 56249131708     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-012455900-4/50293-2     Document Type: Chapter

References (34)

1. Ahmed S.A., Gogal R.M., Walsh J.E. A new rapid and simple non-radioactive assay to monitor and determine the proliferation of lymphocytes: an alternative to [3H]thymidine incorporation assay. J Immunol Methods 1994, 170:211-224.
2. Allsopp C.E.M., Nicholls S.J., Langjorne J. A flow cytometric method to assess antigen-specific proliferative responses of different subpopulations of fresh and cryopreserved human peripheral blood mononuclear cells. J Immunol Methods 1998, 214:175-186.
3. Bach R.H., Hirschhorn K. Lymphocyte interaction: a potential histocompatibility rest in vitro. Science 1964, 143:813-814.
4. Bagwell C.B. Theoretical aspects of data analysis. Clinical Flow Cytometry 1993, 41. Williams and Wilkins, Baltimore. K.D. Bauer, R.E. Duque, T.V. Shankey (Eds.).
5. Barten M.J., Gummert J.F., van Gelder T., Shorthouse R., Morris R.E. Flow cytometric quantitation of calcium-dependent and -independent mitogen-stimulation of T cell functions in whole blood; inhibition by immunosuppressive drugs in vitro. J Immunol Methods 2001, 253:95-112.
6. Bercovici N., Duffour M.T., Agarwal S., Salacedo M., Abastado J.P. New methods for assessing T-cell responses. Clin Diagn Lab Immunol 2000, 7:859.
7. Bercovici N., Givan A.L., Waugh M.G., et al. Multiparameter precursor analysis of T-cell responses to antigen. J Immunol Methods 2003, 276:5-17.
8. Black C.A. Delayed type hypersensitivity: current theories with an historic perspective. J Dermatol Online Review 1999, 5:7.
9. Champagne P., Ogg G.S., King A.S., et al. Skewed maturation of memory HIV-specific CD8+ T lymphocytes. Nature 2001, 410:106-111.
10. Dionigi P., Ferrari A., Jemos V., et al. Tumor cell proliferation in early gastric cancer: biological and clinical behavior. Hepatogastroenterology 2004, 51:264-268.
11. Fletcher M.A., Baron G.A., Ashman M.A., Klimas N.G. Use of whole blood methods in assessment of immune parameters in immunodeficiency syndromes. Clin Diag Immunol 1987, 5:69-81.
12. Fulcher D., Wong S. Carboxyfluorescein succinimidyl ester-based proliferative assays for assessment of T cell function in the diagnostic laboratory. Immunol Cell Biol 1999, 77:559-564.
13. Givan A.L., Fisher J.L., Waugh M., Ernstoff M.S., Wallace P.K. A flow cytometric method to estimate the precursor frequencies of cells proliferating in response to specific antigens. J Immunol Methods 1999, 230:99-112.
14. Horan P.K., Slezak S.E. Stable cell membrane labeling. Nature 1989, 340:167-168.
15. Kaech S.M., Wherry E.J., Ahmed R. Effector and memory T-cell differentiation: implications for vaccine development. Nat Rev Immunol 2002, 2:251-262.
16. Kaminski E., Hows J., Brookes P., et al. Alloreactive cytotoxic T-cell frequency analysis and HLA matching for bone marrow transplants from HLA matched unrelated donors. Transplant Proc 1989, 21:2976-2977.
17. Kaminski E., Hows J., Man S., et al. Prediction of graft versus host disease by frequency analysis of cytotoxic T cells after unrelated donor bone marrow transplantation. Transplantation 1989, 48:608-613.
18. Kovacs J.A., Lempicki R.A., Sidorov I.A., et al. Identification of dynamically distinct subpopulations of T lymphocytes that are differentially affected by HIV. J Exp Med 2001, 194:1731-1741.
19. Lanzavecchia A., Sallusto F. Dynamics of T lymphocyte responses: intermediates, effectors, and memory cells. Science 2000, 290:92-97.
20. Lefkovits I., Waldmann H. Limiting dilution analysis of cells in the immune system 1999, Cambridge University Press, Cambridge.
21. Lyons A.B., Parish C.R. Determination of lymphocyte division by flow cytometry. J Immunol Meth 1994, 171:131-137.
22. Lyons A.B. Divided we stand: tracking cell proliferation with carboxyfluorescein diacetate succinimidyl ester. Immunol Cell Biol 1999, 77:509-515.
23. Meidenbauer N., Harris D.T., Spitler L.E., Whiteside T.L. Generation of PSA-reactive effector cells after vaccination with a PSA-based vaccine in patients with prostate cancer. Prostate 2000, 43:88-100.
24. Miyamoto S., Kimball S.R., Safer B. Signal transduction pathways that contribute to increased protein synthesis during T-cell activation. Biochim Biophys Acta 2000, 1494:28-42.
25. Moretta A., Pantaleo G., Moretta M., Cerottini J-C., Mingari C.M. Direct demonstration of the clonogenic potential of every human peripheral blood T cell. Clonal analysis of HLA-DR expression and cytolytic activity. J Exp Med 1983, 157:743-754.
26. Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 1983, 65:55-63.
27. Reinsmoen N.L., Kaufman D., Sutherland D., Matas A.J., Najarian J.S., Bach F.H. A new in vitro approach to determine acquired tolerance in long-term kidney allograft recipients. Transplantation 1990, 50:783-789.
28. Reinsmoen N.L., Matas A.J. Evidence that improved late renal transplant outcome correlates with the development of in vitro donor antigen-specific hypo-reactivity. Transplantation 1993, 55:1017-1023.
29. Riss T.L., Moravec R.A. Comparison of MTT, XTT and a novel tetrazolium compound MTS for in vitro proliferation and chemosensitivity assays. Mol Biol Cell 1992, 3:184a.
30. Savitskiy V.P., Shman T.V., Potapnev M.P. Comparative measurement of spontaneous apoptosis in pediatric acute leukemia by different techniques. Cytometry 2003, 56:16-22.
31. Schultes B., Whiteside T.L. Monitoring of immune responses to CA125 with an IFNγ ELISPOT assay. J Immunol Methods 2003, 279:1-15.
32. Sharrock C.E.M., Kaminski E., Man S. Limiting dilution analysis of human T cells: a useful clinical tool. Immunol Today 1990, 11:281-283.
33. Vose B.M., Vanky F., Klein E. Human tumour-lymphocyte interactions in vitro. V. Comparison of the reactivity of tumour-infiltrating, blood and lymph-node lymphocytes with autologous tumor cells. Int J Cancer 1977, 20:895-899.
34. Whiteside T.L. Tumor-infiltrating lymphocytes in human malignancies 1993, Medical Intelligence Unit, R.G. Lands Co., Austin, TX.